Retail Roundup

Date: 
Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

The American Academy of Orthopedic Surgeons (AAOS) has historically recommended antibiotic premedication in select patients with hip or knee implants undergoing medical or dental procedures that produce bacteremia. These individua...

View Blog Post
Blog Post

April is National Minority Health Month. Follow events and discussions at #NMHM17. The theme of the U.S. Department of Health & Human Services’

View Blog Post
Blog Post

Healthcare professionals around the world have been concerned by alarming medical error statistics in recent studies, particularly those involving medications. Errors involving incorrect dosing, dispensing, or administration of me...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up